Phoenix, AZ— bioSyntagma, LLC, a developer of life science tools for single and multi-cell analysis announced today it has been has been awarded a National Science Foundation (NSF) Phase II Small Business Innovation Research (SBIR) grant of $735,139.Continue reading→

SMS archiving technology patented by CellTrust is fundamental for successful e-compliance enforcement for the highly regulated financial services, government and healthcare industries.Continue reading→

A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast cancer tumors, producing several new therapeutic candidates for this difficult-to-treat cancer.Continue reading→

A Tempe bioscience firm selling its DNA analysis kits to 25 countries worldwide is expanding into the education sector.Continue reading→

NuvOx Pharma, a clinical stage biotechnology company, announces that the FDA has allowed a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe). Continue reading→

An Arizona State University team won $100,000 at the ASU Innovation Open on Friday to fund their business, which makes a device that relieves anxiety.Continue reading→

Amid the national opioid crisis, “Integrative Approaches to Pain Management” teaches health-care professionals non-pharmaceutical options.Continue reading→

Response is sign of potential loss of consciousnessContinue reading→